DAB urges tighter embryo biopsy checks in Hong Kong
SCMP · 1 SOURCESabout 20 hours ago2 MIN
Summary
Hong Kong’s DAB has urged the government to tighten controls over embryo biopsy handling and amend reproductive technology rules after specimens sent for genetic testing were found to belong to the wrong parents at Heal Fertility in Central . The party said the incident exposed gaps in the current two-person verification system and in reporting requirements, which it argued lack sufficient legal force .
Key Points
- DAB issued its proposals on Thursday, nearly a month after the Council on Human Reproductive Technology suspended most operations at Heal Fertility in Central .
- Lawmaker Nixie Lam said mandatory two-person verification currently does not cover every stage of embryo biopsy handling and transfer procedures .
- The party proposed double-checking and record-keeping at extraction, sealing, transport, and laboratory receiving for every embryo biopsy specimen .
- Lam said authorities should receive immediate notification, criticising that the Department of Health was not informed until July 3 .
- Hong Kong’s reproductive technology sector is overseen by a statutory council established in 2001, with 13 public and 15 private licensed organisations .
Why It Matters
The case has raised concerns about patient protection, chain-of-custody controls, and whether existing professional codes are strong enough to prevent or quickly contain serious reproductive technology errors . Pressure is likely to grow for faster incident reporting, stricter compliance rules, and possible legal amendments affecting fertility clinics across Hong Kong .